Vanguard ESG Developed Europe All Cap UCITS ETF (AMS:V3EA)
Netherlands · Delayed Price · Currency is EUR 6.92
+0.01 (0.10%)
At close: Dec 5, 2025
12.02% (1Y)
| Assets | 145.25M |
| Expense Ratio | 0.12% |
| PE Ratio | 13.12 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | +12.02% |
| Volume | 2,341 |
| Open | 6.93 |
| Previous Close | 6.92 |
| Day's Range | 6.93 - 6.95 |
| 52-Week Low | 5.59 |
| 52-Week High | 6.97 |
| Beta | n/a |
| Holdings | 987 |
| Inception Date | Aug 16, 2022 |
About V3EA
V3DA.SW was created on 2022-08-16 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. This Fund seeks to track the performance of the Index.
Asset Class Equity
Category Total Market
Stock Exchange Euronext Amsterdam
Ticker Symbol V3EA
Provider Vanguard
Index Tracked FTSE Developed Europe All Cap Choice Index - EUR - Benchmark TR Net
Performance
V3EA had a total return of 12.02% in the past year, including dividends. Since the fund's inception, the average annual return has been 11.27%.
Top 10 Holdings
22.96% of assets| Name | Symbol | Weight |
|---|---|---|
| ASML Holding N.V. | ASML | 4.17% |
| SAP SE | SAP | 2.66% |
| AstraZeneca PLC | AZN | 2.45% |
| Nestlé S.A. | NESN | 2.42% |
| Novartis AG | NOVN | 2.31% |
| Roche Holding AG | ROG | 2.26% |
| Siemens Aktiengesellschaft | SIE | 2.08% |
| Novo Nordisk A/S | NOVO.B | 1.55% |
| Allianz SE | ALV | 1.55% |
| Banco Santander, S.A. | SAN | 1.51% |